EuroEyes International Eye Clinic Limited

SEHK:1846 Stock Report

Market Cap: HK$1.9b

EuroEyes International Eye Clinic Management

Management criteria checks 4/4

EuroEyes International Eye Clinic's CEO is Jörn Jörgensen, appointed in Mar 2019, has a tenure of 5.17 years. total yearly compensation is HK$2.71M, comprised of 86.7% salary and 13.3% bonuses, including company stock and options. directly owns 53.9% of the company’s shares, worth HK$1.03B. The average tenure of the management team and the board of directors is 5.2 years and 5.2 years respectively.

Key information

Jörn Jörgensen

Chief executive officer

HK$2.7m

Total compensation

CEO salary percentage86.7%
CEO tenure5.2yrs
CEO ownership53.9%
Management average tenure5.2yrs
Board average tenure5.2yrs

Recent management updates

Recent updates

EuroEyes International Eye Clinic's (HKG:1846) Dividend Will Be Reduced To HK$0.0489

Apr 25
EuroEyes International Eye Clinic's (HKG:1846) Dividend Will Be Reduced To HK$0.0489

EuroEyes International Eye Clinic's (HKG:1846) Dividend Will Be Reduced To HK$0.0489

Mar 31
EuroEyes International Eye Clinic's (HKG:1846) Dividend Will Be Reduced To HK$0.0489

What Is EuroEyes International Eye Clinic Limited's (HKG:1846) Share Price Doing?

Nov 21
What Is EuroEyes International Eye Clinic Limited's (HKG:1846) Share Price Doing?

Analysts Have Just Cut Their EuroEyes International Eye Clinic Limited (HKG:1846) Revenue Estimates By 15%

Sep 08
Analysts Have Just Cut Their EuroEyes International Eye Clinic Limited (HKG:1846) Revenue Estimates By 15%

EuroEyes International Eye Clinic Limited (HKG:1846) Shares Could Be 24% Below Their Intrinsic Value Estimate

Jul 31
EuroEyes International Eye Clinic Limited (HKG:1846) Shares Could Be 24% Below Their Intrinsic Value Estimate

Analysts Just Made A Major Revision To Their EuroEyes International Eye Clinic Limited (HKG:1846) Revenue Forecasts

Apr 25
Analysts Just Made A Major Revision To Their EuroEyes International Eye Clinic Limited (HKG:1846) Revenue Forecasts

There Are Reasons To Feel Uneasy About EuroEyes International Eye Clinic's (HKG:1846) Returns On Capital

Dec 05
There Are Reasons To Feel Uneasy About EuroEyes International Eye Clinic's (HKG:1846) Returns On Capital

EuroEyes International Eye Clinic (HKG:1846) Will Pay A Larger Dividend Than Last Year At HK$0.099

May 26
EuroEyes International Eye Clinic (HKG:1846) Will Pay A Larger Dividend Than Last Year At HK$0.099

EuroEyes International Eye Clinic's (HKG:1846) Upcoming Dividend Will Be Larger Than Last Year's

May 12
EuroEyes International Eye Clinic's (HKG:1846) Upcoming Dividend Will Be Larger Than Last Year's

EuroEyes International Eye Clinic's (HKG:1846) Dividend Will Be Increased To HK$0.099

Apr 27
EuroEyes International Eye Clinic's (HKG:1846) Dividend Will Be Increased To HK$0.099

EuroEyes International Eye Clinic (HKG:1846) Is Increasing Its Dividend To HK$0.099

Apr 08
EuroEyes International Eye Clinic (HKG:1846) Is Increasing Its Dividend To HK$0.099

Slowing Rates Of Return At EuroEyes International Eye Clinic (HKG:1846) Leave Little Room For Excitement

Mar 07
Slowing Rates Of Return At EuroEyes International Eye Clinic (HKG:1846) Leave Little Room For Excitement

Is Now An Opportune Moment To Examine EuroEyes International Eye Clinic Limited (HKG:1846)?

Jan 18
Is Now An Opportune Moment To Examine EuroEyes International Eye Clinic Limited (HKG:1846)?

The Returns At EuroEyes International Eye Clinic (HKG:1846) Aren't Growing

Nov 02
The Returns At EuroEyes International Eye Clinic (HKG:1846) Aren't Growing

There Are Reasons To Feel Uneasy About EuroEyes International Eye Clinic's (HKG:1846) Returns On Capital

May 20
There Are Reasons To Feel Uneasy About EuroEyes International Eye Clinic's (HKG:1846) Returns On Capital

Is There An Opportunity With EuroEyes International Eye Clinic Limited's (HKG:1846) 42% Undervaluation?

Mar 29
Is There An Opportunity With EuroEyes International Eye Clinic Limited's (HKG:1846) 42% Undervaluation?

Who Has Been Buying EuroEyes International Eye Clinic Limited (HKG:1846) Shares?

Mar 08
Who Has Been Buying EuroEyes International Eye Clinic Limited (HKG:1846) Shares?

If You Had Bought EuroEyes International Eye Clinic (HKG:1846) Stock A Year Ago, You Could Pocket A 16% Gain Today

Feb 06
If You Had Bought EuroEyes International Eye Clinic (HKG:1846) Stock A Year Ago, You Could Pocket A 16% Gain Today

CEO Compensation Analysis

How has Jörn Jörgensen's remuneration changed compared to EuroEyes International Eye Clinic's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

HK$131m

Sep 30 2023n/an/a

HK$121m

Jun 30 2023n/an/a

HK$110m

Mar 31 2023n/an/a

HK$100m

Dec 31 2022HK$3mHK$2m

HK$89m

Sep 30 2022n/an/a

HK$102m

Jun 30 2022n/an/a

HK$115m

Mar 31 2022n/an/a

HK$124m

Dec 31 2021HK$3mHK$3m

HK$134m

Sep 30 2021n/an/a

HK$123m

Jun 30 2021n/an/a

HK$113m

Mar 31 2021n/an/a

HK$89m

Dec 31 2020HK$360kn/a

HK$66m

Sep 30 2020n/an/a

HK$38m

Jun 30 2020n/an/a

HK$10m

Mar 31 2020n/an/a

HK$5m

Dec 31 2019HK$272kn/a

-HK$3m

Compensation vs Market: Jörn's total compensation ($USD346.80K) is about average for companies of similar size in the Hong Kong market ($USD330.03K).

Compensation vs Earnings: Jörn's compensation has been consistent with company performance over the past year.


CEO

Jörn Jörgensen (68 yo)

5.2yrs

Tenure

HK$2,710,000

Compensation

Dr. Jörn Slot Jörgensen serves as Executive Chairman of the Board and Chief Executive Officer at EuroEyes International Eye Clinic Limited since March 25, 2019. He joined EuroEyes International Eye Clinic...


Leadership Team

NamePositionTenureCompensationOwnership
Jörn Jörgensen
Founder5.2yrsHK$2.71m53.9%
HK$ 1.0b
Markus Braun
CFO & Executive Director5.2yrsHK$2.02m0.085%
HK$ 1.6m
Jannik Jørgensen
VP of Denmark & Executive Director5.2yrsHK$630.00k1.87%
HK$ 35.9m
Daniel Reinstein
Executive Director1.8yrsHK$4.53m0.73%
HK$ 14.0m
Michael Knorz
Senior Vice President of Medical Affairs (International)5.2yrsno datano data
Keith Mckay
Senior Vice President of Operations (Germany)5.2yrsno datano data
Jörg Hassel
Senior Consultant of Operations5.2yrsno datano data
Lars Boberg-Ans
Senior Vice President of Denmark5.2yrsno datano data
Rosenna Ho
Company Secretary4.1yrsno datano data

5.2yrs

Average Tenure

60yo

Average Age

Experienced Management: 1846's management team is seasoned and experienced (5.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Jörn Jörgensen
Founder5.8yrsHK$2.71m53.9%
HK$ 1.0b
Markus Braun
CFO & Executive Director5.4yrsHK$2.02m0.085%
HK$ 1.6m
Jannik Jørgensen
VP of Denmark & Executive Director5.2yrsHK$630.00k1.87%
HK$ 35.9m
Daniel Reinstein
Executive Director1.8yrsHK$4.53m0.73%
HK$ 14.0m
Marcus Bracklo
Non-Executive Director & Strategic Advisor5.2yrsHK$672.00k0.082%
HK$ 1.6m
Hans Hennig
Independent Non-Executive Director5.2yrsHK$360.00kno data
Xin Rong
Independent Non-Executive Director3.1yrsHK$360.00kno data
Philip Wright
Independent Non Executive Director5.2yrsHK$360.00kno data

5.2yrs

Average Tenure

59.5yo

Average Age

Experienced Board: 1846's board of directors are considered experienced (5.2 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.